Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor

Pediatr Hematol Oncol. 2020 Aug;37(5):445-449. doi: 10.1080/08880018.2020.1735591. Epub 2020 Mar 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Celecoxib / therapeutic use*
  • Child
  • Cyclooxygenase 2 / metabolism
  • Fibromatosis, Aggressive / diagnosis
  • Fibromatosis, Aggressive / drug therapy*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Protein Kinase Inhibitors / therapeutic use
  • Receptors, Platelet-Derived Growth Factor / metabolism
  • Risk Factors
  • Sorafenib / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Protein Kinase Inhibitors
  • Sorafenib
  • Cyclooxygenase 2
  • Receptors, Platelet-Derived Growth Factor
  • Celecoxib